| |
|
|
| Name: |
Kynam Capital Management LP |
| City: |
PRINCETON |
| State: |
NJ |
| Zip: |
08540 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
8 |
|
View All Holdings |
Currently
Viewing:
Decreased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NTRA |
Natera, Inc. |
1 |
- |
$108.31 |
$182,920,000 |
2,000,000 |
20.35% |
32,584,000 |
-400,000 |
1.745 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
3 |
- |
$33.47 |
$121,713,000 |
2,900,000 |
13.54% |
2,499,000 |
-105,904 |
4.611 |
Diagnostic Substances |
|
|
VERA |
Vera Therapeutics, Inc. |
4 |
- |
$0.00 |
$65,835,000 |
1,526,787 |
7.32% |
9,693,000 |
-2,123,552 |
3.606 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
7 |
- |
$0.00 |
$50,891,000 |
745,000 |
5.66% |
-12,060,000 |
-257,407 |
0.691 |
N/A |
|
|
LQDA |
Liquidia Technologies Inc |
8 |
- |
$14.50 |
$33,163,000 |
2,248,324 |
3.69% |
702,000 |
-450,000 |
5.956 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
10 |
- |
$29.81 |
$33,103,000 |
1,144,242 |
3.68% |
-12,869,000 |
-860,633 |
1.984 |
N/A |
|
|
SLRN |
Acelyrin, Inc. |
20 |
- |
$4.10 |
$2,676,000 |
396,379 |
0.3% |
-6,276,000 |
-803,621 |
0.408 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
21 |
- |
$12.00 |
$2,344,000 |
133,877 |
0.26% |
-10,896,000 |
-474,038 |
0.213 |
N/A |
|
